Jianjun Liu

ORCID: 0000-0003-3479-3849
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Medical Imaging Techniques and Applications
  • Radiomics and Machine Learning in Medical Imaging
  • Radiopharmaceutical Chemistry and Applications
  • Prostate Cancer Treatment and Research
  • Cancer, Hypoxia, and Metabolism
  • MRI in cancer diagnosis
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Prostate Cancer Diagnosis and Treatment
  • Peptidase Inhibition and Analysis
  • Advanced X-ray and CT Imaging
  • Advanced MRI Techniques and Applications
  • Gastric Cancer Management and Outcomes
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Lymphoma Diagnosis and Treatment
  • Advanced Radiotherapy Techniques
  • Renal cell carcinoma treatment
  • Colorectal Cancer Surgical Treatments
  • Urinary and Genital Oncology Studies
  • Bladder and Urothelial Cancer Treatments
  • Cancer-related Molecular Pathways
  • Anesthesia and Pain Management
  • Cardiac tumors and thrombi
  • Renal and related cancers
  • Autoimmune Neurological Disorders and Treatments

Shanghai Jiao Tong University
2016-2025

Renji Hospital
2016-2025

Second Hospital of Anhui Medical University
2024

Anhui Medical University
2024

Shanghai University of Medicine and Health Sciences
2023

Jiangnan University
2021

Hebei Medical University
2021

Xingtai People's Hospital
2021

Southwest Hospital
2019

Army Medical University
2019

10.1007/s00259-022-05723-x article EN European Journal of Nuclear Medicine and Molecular Imaging 2022-02-11

<sup>68</sup>Ga-prostate-specific membrane antigen (<sup>68</sup>Ga-PSMA) PET/CT is a commonly used imaging modality in prostate cancers. However, few studies have compared the diagnostic efficiency between <sup>68</sup>Ga-PSMA and <sup>18</sup>F-FDG evaluated whether heterogeneous metabolic phenotype (especially <sup>68</sup>Ga-PSMA–negative [−], <sup>18</sup>F-FDG–positive [+] lesions) exists patients with castration-resistant cancer (CRPC). We determined added value of CRPC identified who...

10.2967/jnumed.120.262250 article EN Journal of Nuclear Medicine 2022-01-01

<sup>18</sup>F-FDG PET has been widely used in the management of malignant tumors. In gastric cancer, status human epidermal growth factor receptor 2 (HER2) predicts response to anti-HER2 antibody therapy, and testing HER2 expression is now routine cancer patients. However, date, relationship between uptake not, our knowledge, investigated. this study, we aimed investigate whether associated with PET/CT can be predict cancer. <b>Methods:</b> A retrospective analysis was performed on 64...

10.2967/jnumed.115.171165 article EN Journal of Nuclear Medicine 2016-03-10

// Mingge Zhou 1 , Yumei Chen Honghui Huang 2 Xiang Jianjun Liu Gang Department of Nuclear Medicine, Ren Ji Hospital, School Shanghai Jiao Tong University, Shanghai, China Hematology, Correspondence to: Huang, email: huang2802@163.com Liu, nuclearj@163.com Keywords: DLBCL, prognosis, PET/CT, TLG, MTV Received: September 18, 2016&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accepted: October 14, Published: November 07, 2016 ABSTRACT Purpose : We evaluated the prognostic value total lesion glycolysis (TLG)...

10.18632/oncotarget.13180 article EN Oncotarget 2016-11-07

<sup>18</sup>F-FDG PET has been widely used in the management of malignant tumors. Lactate dehydrogenase A (LDHA) plays an important role development, invasion, and metastasis malignancies. However, relationship between accumulation LDHA expression not investigated. <b>Methods:</b> Retrospective analysis was conducted for 51 patients with lung adenocarcinomas who underwent PET. The maximum standardized uptake value LDHA, glucose transporter 1 (GLUT1), hexokinase 2 (HK2) were examined. RNA...

10.2967/jnumed.114.145490 article EN Journal of Nuclear Medicine 2014-10-23

Combination chemotherapy is a potentially promising approach to enhance anticancer activity, overcome drug resistance, and improve disease-free overall survival. The current study investigates the antitumor activity of sodium dichloroacetic acid (DCA) in combination with SIRT2 inhibitor Sirtinol AGK2. We found that combining DCA produced synergistic therapeutic benefit A549 H1299 NSCLC cells vitro mouse xenograft model. Synergistic potentiation oxidative phosphorylation (OXPHOS) was...

10.1080/15384047.2018.1480281 article EN Cancer Biology & Therapy 2018-08-01

Previous studies have demonstrated that delayed [68 Ga]Ga-PSMA PET/CT imaging improves lesion detection compared to early in patients with prostate cancer. However, the sole use of has been limited due insufficient number photons obtained standard scanners. The combination and may be considered, it is challenging incorporate into a high-demand clinical setting. Long field-of-view (LFOV) scanners higher sensitivity PET/CT. remains unknown whether image quality solitary LFOV adequate satisfy...

10.1186/s13550-024-01076-8 article EN cc-by EJNMMI Research 2024-02-06

Fast PET imaging is clinically important for reducing motion artifacts and improving patient comfort. While recent diffusion-based deep learning methods have shown promise, they often fail to capture the true degradation process, suffer from accumulated inference errors, introduce artifacts, require extensive reconstruction iterations. To address these challenges, we propose a novel multistage diffusion framework tailored fast imaging. At coarse level, design structure approximate temporal...

10.1109/jbhi.2025.3567645 article EN IEEE Journal of Biomedical and Health Informatics 2025-01-01

Lactate dehydrogenase B (LDHB) is widely expressed in adult somatic tissue and plays important roles the development of human cancers. However, association between LDHB expression clinicopathological characteristics hepatocellular carcinoma (HCC) not well understood. The study was to detect HCC investigate its HCC. Immunohistochemistry (IHC) analysis performed characterize matched noncancerous tissues. Kaplan–Meier survival Cox regression analyses were employed evaluate prognosis 75...

10.1097/md.0000000000001583 article EN cc-by-nc Medicine 2015-09-01
Coming Soon ...